301 Binney St. 3rd FloorDownload Project Profile
About the project
Even though Affinivax was deemed essential as a vaccine lab during the covid-19 pandemic, and construction was allowed to proceed, the virus had an impact on almost every aspect of the project. It was challenging for everyone but with some innovation and much teamwork we pulled it off, and the project is currently on schedule to complete later this year.
Affinivax secured a lease of around 47,000sf at 301 Binney Street, Cambridge, with the intention of building it out to include their company headquarters and an R&D Lab
Hereva Consultants was hired to provide project services from planning through modifications, and into relocation and move-in. We also provided support during operational start-up.
Our project management team developed early stage understanding of the project’s needs, and provided scope validation/generation, schedule, high-level budget compilation services and real-time cost management during project delivery. In addition, we worked with their internal team assisting with approval and procurement of external services as needed, such as design and construction team members.
About the client
Affinivax is a clinical stage biotechnology company with a next generation Multiple Antigen Presentation System (MAPS) vaccine technology platform creating novel vaccines and immunotherapies inducing a broader and more robust immune response.